| P50 | author | Julie A Lovegrove | Q58658006 |
| P2093 | author name string | D Ian Givens | |
| | Ágnes A Fekete | |
| P2860 | cites work | Calcium supplementation for the management of primary hypertension in adults | Q24246127 |
| | The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence | Q24634423 |
| | Oxidative stress in hypertension | Q28217587 |
| | Global burden of hypertension: analysis of worldwide data | Q28302545 |
| | Peroxynitrite: biochemistry, pathophysiology and development of therapeutics | Q29615424 |
| | Caseins and casein hydrolysates. 2. Antioxidative properties and relevance to lipoxygenase inhibition. | Q31916615 |
| | Current concepts in assessment of microvascular endothelial function using laser Doppler imaging and iontophoresis | Q33343811 |
| | Long-term intervention with Lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects. | Q33800305 |
| | Acute reduction of blood pressure by nitroglycerin does not normalize large artery stiffness in essential hypertension | Q33998526 |
| | Lactotripeptides and antihypertensive effects: a critical review | Q34015048 |
| | Effects of milk-derived bioactives: an overview. | Q34176970 |
| | 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension | Q34274434 |
| | Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats | Q34413834 |
| | Fundamentals of endothelial function for the clinical cardiologist | Q34517868 |
| | Long-term effects of a protein-enriched diet on blood pressure in older women | Q34632215 |
| | High-sugar diets increase cardiac dysfunction and mortality in hypertension compared to low-carbohydrate or high-starch diets. | Q35012934 |
| | Bioavailability of angiotensin I converting enzyme inhibitory peptides | Q35911215 |
| | Relations between dairy food intake and arterial stiffness: pulse wave velocity and pulse pressure. | Q35926387 |
| | Food-derived peptides with biological activity: from research to food applications | Q36733200 |
| | Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production | Q36789704 |
| | Skin blood flow responses to the iontophoresis of acetylcholine and sodium nitroprusside in man: possible mechanisms. | Q36831464 |
| | Ethnic differences in dairy and related nutrient consumption among US adults and their association with obesity, central obesity, and the metabolic syndrome | Q36979730 |
| | Antihypertensive peptides derived from bovine casein and whey proteins | Q37053769 |
| | Acute ingestion of a novel whey-derived peptide improves vascular endothelial responses in healthy individuals: a randomized, placebo controlled trial | Q37295459 |
| | Lactopeptides and human blood pressure. | Q37626383 |
| | Milk in the diet: good or bad for vascular disease? | Q37945795 |
| | Acute effects of ingestion of a novel whey-derived extract on vascular endothelial function in overweight, middle-aged men and women | Q39604163 |
| | Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force | Q39605814 |
| | Dietary calcium and blood pressure in experimental models of hypertension. A review | Q40733852 |
| | Casein phosphopeptide (CPP) enhances calcium absorption from the ligated segment of rat small intestine. | Q41469188 |
| | Analgesic activity of intracerebroventricular administration of morphiceptin and β-casomorphins: Correlation with the morphine (μ) receptor binding affinity | Q41553102 |
| | Human in vivo study of the renin-angiotensin-aldosterone system and the sympathetic activity after 8 weeks daily intake of fermented milk | Q43180465 |
| | Additive beneficial effects of lactotripeptides intake with regular exercise on endothelium-dependent dilatation in postmenopausal women. | Q43193941 |
| | The chronic effects of whey proteins on blood pressure, vascular function, and inflammatory markers in overweight individuals | Q43247470 |
| | Additive beneficial effects of lactotripeptides and aerobic exercise on arterial compliance in postmenopausal women. | Q43270602 |
| | Nitric oxide regulates local arterial distensibility in vivo | Q43854309 |
| | Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study | Q43859232 |
| | Effect of long-term intake of milk products on blood pressure in hypertensive rats. | Q44016116 |
| | Opioid activities and structures of .alpha.-casein-derived exorphins | Q44353498 |
| | Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen | Q44690025 |
| | A randomized, double-blind, placebo-controlled trial of casein protein hydrolysate (C12 peptide) in human essential hypertension | Q45144310 |
| | Preparation of antioxidant enzymatic hydrolysates from alpha-lactalbumin and beta-lactoglobulin. Identification of active peptides by HPLC-MS/MS. | Q45247768 |
| | The lactotripeptides isoleucine-proline-proline and valine-proline-proline do not inhibit the N-terminal or C-terminal angiotensin converting enzyme active sites in humans. | Q45977596 |
| | The angiotensin converting enzyme inhibitory tripeptides Ile-Pro-Pro and Val-Pro-Pro show increasing permeabilities with increasing physiological relevance of absorption models. | Q46587728 |
| | Lactotripeptides effect on office and 24-h ambulatory blood pressure, blood pressure stress response, pulse wave velocity and cardiac output in patients with high-normal blood pressure or first-degree hypertension: a randomized double-blind clinical | Q46666157 |
| | Relationship between oxidative stress and essential hypertension | Q46698561 |
| | Derivatives of beta-casomorphins with high analgesic potency | Q46890953 |
| | Inverse association between dairy intake and hypertension: the Rotterdam Study | Q46921341 |
| | Release of angiotensin I converting enzyme (ACE) inhibitory activity during in vitro gastrointestinal digestion: from batch experiment to semicontinuous model. | Q49024233 |
| | The impact of fermentation and in vitro digestion on the formation of angiotensin-I-converting enzyme inhibitory activity from pea and whey protein. | Q49032342 |
| | Blood pressure and heart rate variabilities in normotensive and hypertensive human beings | Q49108735 |
| | Acute effects of whey protein isolate on blood pressure, vascular function and inflammatory markers in overweight postmenopausal women. | Q51380836 |
| | Effect of a milk drink supplemented with whey peptides on blood pressure in patients with mild hypertension. | Q51483001 |
| | Functional foods and coronary heart disease (CHD) | Q57711989 |
| | Effect of heat and enzymatic treatment on the antihypertensive activity of whey protein hydrolysates | Q59379913 |
| | Dairy calcium intake modifies responsiveness of fat metabolism and blood lipids to a high-fat diet | Q59711863 |
| | Fructose-induced hypertension in rats is concentration- and duration-dependent | Q72278323 |
| | Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk | Q72334244 |
| | Effect of administration of fermented milk containing whey protein concentrate to rats and healthy men on serum lipids and blood pressure | Q73543265 |
| | Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease | Q73708513 |
| | Alpha-lactorphin lowers blood pressure measured by radiotelemetry in normotensive and spontaneously hypertensive rats | Q73742481 |
| | Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men | Q74026236 |
| | Bovine casein hydrolysate (c12 Peptide) reduces blood pressure in prehypertensive subjects | Q79470514 |
| | Arterial blood pressure and stiffness in hypertension: is arterial structure important? | Q80111728 |
| | Structural analysis of a new anti-hypertensive peptide (beta-lactosin B) isolated from a commercial whey product | Q80489799 |
| | Deleterious effects of sugar and protective effects of starch on cardiac remodeling, contractile dysfunction, and mortality in response to pressure overload | Q80580053 |
| | Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme | Q80705762 |
| | Arterial stiffness and hypertension: a two-way street? | Q81400931 |
| | Change in body mass index and its impact on blood pressure: a prospective population study | Q81612072 |
| | Ile-Pro-Pro and Val-Pro-Pro tripeptide-containing milk product has acute blood pressure lowering effects in mildly hypertensive subjects | Q84294907 |
| | Casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro improves central blood pressure and arterial stiffness in hypertensive subjects: a randomized, double-blind, placebo-controlled trial | Q84491082 |
| P433 | issue | 2 | |
| P304 | page(s) | 177-190 | |
| P577 | publication date | 2013-10-18 | |
| P1433 | published in | Nutrition Research Reviews | Q15757719 |
| P1476 | title | The impact of milk proteins and peptides on blood pressure and vascular function: a review of evidence from human intervention studies | |
| P478 | volume | 26 | |